Catalogo dei prodotti della ricerca

SALCICCIA, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.471
EU - Europa 1.673
AS - Asia 1.165
AF - Africa 50
SA - Sud America 27
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.430
IT - Italia 720
SG - Singapore 492
CN - Cina 320
IN - India 270
SE - Svezia 228
UA - Ucraina 178
FI - Finlandia 165
DE - Germania 150
GB - Regno Unito 51
ID - Indonesia 45
BG - Bulgaria 43
TG - Togo 43
CA - Canada 36
BE - Belgio 20
IE - Irlanda 17
AR - Argentina 16
NL - Olanda 15
PL - Polonia 15
FR - Francia 14
RU - Federazione Russa 12
CL - Cile 9
PH - Filippine 9
RO - Romania 9
MK - Macedonia 8
CH - Svizzera 6
IR - Iran 6
LT - Lituania 6
AU - Australia 5
IL - Israele 5
MX - Messico 5
HK - Hong Kong 4
ES - Italia 3
JP - Giappone 3
LU - Lussemburgo 3
ZA - Sudafrica 3
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SC - Seychelles 2
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
LB - Libano 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VN - Vietnam 1
Totale 8.394
Salva come PNG Salva come JPEG
Città #
Fairfield 899
Chandler 447
Woodbridge 434
Ashburn 370
Singapore 355
Houston 332
Seattle 328
Rome 311
Cambridge 278
Wilmington 257
Ann Arbor 204
Santa Clara 186
Princeton 165
San Paolo di Civitate 117
Plano 110
Millbury 95
Lawrence 84
Beijing 83
San Diego 79
Jacksonville 61
Helsinki 56
Munich 51
Jakarta 44
Lomé 43
Sofia 43
Boston 38
Hefei 38
Andover 36
Falkenstein 34
Falls Church 31
Milan 30
Boardman 29
Toronto 28
New York 27
Norwalk 27
Des Moines 23
Nanjing 23
Dearborn 22
Kunming 22
San Mateo 19
Brussels 16
Federal 16
Dublin 15
Warsaw 14
Guangzhou 13
Jinan 13
Nanchang 12
Southend 11
London 10
Frankfurt am Main 9
Dallas 8
Fremont 7
Grafing 7
Lappeenranta 7
Los Angeles 7
Mannheim 7
Moscow 7
Ottawa 7
Zhengzhou 7
Amsterdam 6
Auburn Hills 6
Bühl 6
Chengdu 6
Fuzhou 6
Genova 6
Napoli 6
Phoenix 6
Rovato 6
Turin 6
Wuhan 6
Baotou 5
Buffalo 5
Caserta 5
Chongqing 5
Marikina City 5
Paris 5
Ramat Gan 5
Bremen 4
Liège 4
Marano Di Napoli 4
Naples 4
Ningbo 4
Paliano 4
Redmond 4
Stockholm 4
Yantai 4
Cagli 3
Caldarola 3
Changsha 3
Ciudad Obregón 3
Columbus 3
Florence 3
Hebei 3
Hong Kong 3
Hounslow 3
Indiana 3
Las Vegas 3
Modena 3
Olongapo City 3
Sacramento 3
Totale 6.231
Salva come PNG Salva come JPEG
Nome #
Psychological and functional effect of different primary treatments for prostate cancer: a comparative prospective analysis 142
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation 128
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer 113
Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis 101
Chromogranin A expression in familial versus sporadic prostate cancer 99
COMPLETE RESPONSE TO THE COMBINATION THERAPY WITH ANDROGEN BLOCKADE AND SOMATOSTATIN ANALOGUE IN A PATIENT WITH ADVANCED PROSTATE CANCER: MAGNETIC RESONANCE IMAGING WITH 1H-SPECTROSCOPY: Part 2 93
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer 91
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer 89
New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): Current status and future prospects 88
Psychological impact of different primary treatments for prostate cancer. a critical analysis 88
Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy 87
Early recovery of urinary continence after radical prostatectomy using early pelvic floor electric stimulation and biofeedback associated treatment 86
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results 84
In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging 84
"2D AND 3D T2-WEIGHTED MAGNETIC RESONANCE (MR) SEQUENCES FOR THE ASSESSMENT OF NEUROVASCULAR BUNDLES CHANGES AFTER NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY: CORRELATION WITH ERECTILE FUNCTION" 84
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review 83
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone 80
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 78
EARLY RECOVERY OF URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY USING EARLY PELVIC FLOOR ELECTRIC STIMULATION AND BIOFEEDBACK ASSOCIATED TREATMENT 78
Etoricoxib and intermittent androgen deprivation (IAD) therapy in patients with biochemical progression after radical prostatectomy 78
Adjuvant therapy with sorafenib in bone Metastases bilateral renal carcinoma: a case report: Part II 78
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: A critical review 78
Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation 76
Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture 75
Early Recovery of Urinary Continence After Radical Prostatectomy Using Early Pelvic Floor Electrical Stimulation and Biofeedback Associated Treatment 74
Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci 74
Predictors of hospitalization after ureteroscopy plus elective double-j stent as an outpatient procedure 73
Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve sparing radical prostatectomy 73
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy 72
Prognostic predictors in prostate cancer cases with biochemical progression after surgery treated with intermittent androgen deprivation (IAD) 72
USE OF MULTIPARAMETRIC MR WITH NEUROVASCULAR BUNDLE EVALUATION TO OPTIMIZE THE ONCOLOGICAL AND FUNCTIONAL MANAGEMENT OF PATIENTS CONSIDERED FOR NERVE SPARING RADICAL PROSTATECTOMY 72
Prostate cancer unit for an optimal management of prostate cancer unit. ["Prostate cancer unit" per un management ottimale dei pazienti con tumore prostatico] 72
Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy 72
A Novel Therapeutic Option for Castration-resistant Prostate Cancer: After or Before Chemotherapy? 71
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma 71
Chromogranin A and biochemical progression free survival in prostate adenocarcinomas submitted to radical prostatectomy 70
Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): Pattern changes from inflammation to prostate cancer 69
Biopsy-derived gleason artifact and prostate volume: Experience using ten samples in larger prostates 69
Gleason score ≥ 8 prostate adenocarcinoma is associated with higher serum chromogranin A levels also in non metastatic disease. 68
Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes 68
Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report. 68
Is prostate biopsy still necessary? 67
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy 67
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy 67
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 67
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) 67
Recovery of urinary continence after radical prostatectomy using early vs late pelvic floor electrical stimulation and biofeedback-associated treatment 66
Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: Are we ready to treat? 66
Esperienza a lungo termine con un approccio anatomico anterogrado alla prostatectomia radicale (RRP): risultati in termini di margini chirurgici 65
Etoricoxib and intermittent androgen deprivation (IAD) therapy in patients with biochemical progression after radical prostatectomy 65
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models 65
New Treatment Strategies in the Management of Hormone Refractory Prostate Cancer (HRPC): Only Chemotherapy? 65
Update on screening in prostate cancer based on recent clinical trials 64
Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomy 64
Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate 64
Randomized trial comparing an anterograde versus a retrograde approach to open radical prostatectomy: results in terms of positive margin rate 63
Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: Magnetic resonance imaging with 1H-spectroscopy 63
PROGNOSTIC PREDICTORS IN PROSTATE CANCER CASES WITH BIOCHEMICAL PROGRESSION AFTER SURGERY TREATED WITH INTERMITTENT ANDROGEN DEPRIVATION (IAD) 63
Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: A modern approach in prostate cancer imaging 62
Biopsy derived gleason artifact and prostate volume: Experience using 10 samples in larger prostates 62
Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of US claims on perioperative outcomes and health care costs 62
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery 61
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia 61
Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review 61
Correlation between magnetic resonance imaging with 1H-spectroscopy, PSA levels and gleason score in the diagnosis of locally recurrent prostate cancer. 60
null 60
The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach? 59
Distribution of High Chromogranin A Serum Levels in Patients with Nonmetastatic and Metastatic Prostate Adenocarcinoma 59
Use of 3D T2-Weighted MR Sequences for the Assessment of Neurovascular Bundle Changes after Nerve-Sparing Radical Retropubic Prostatectomy (RRP): A Potential Diagnostic Tool for Optimal Management of Erectile Dysfunction after RRP 58
null 58
Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis 58
Association of daily step count and serum testosterone among men in the United States 58
Compared efficacy of adjuvant intravesical bcg-tice vs. bcg-rivm for high-risk non-muscle invasive bladder cancer (nmibc). a propensity score matched analysis 58
Long term patient satisfaction and quality of life with AMS 700 CX inflatable penile prosthesis. 57
Long-term experience with an anatomical anterograde approach to radical prostatectomy: Results in terms of positive margin rate 56
Actual role of multitargeted therapy in renal cell carcinoma (RCC) 55
Inflammation and chronic prostatic diseases: Evidence for a link? 55
Distribution of high chromogranin A (CGA) serum levels in patients with non-metastatic and metastatic prostate adenocarcinoma 54
Cryotherapy for prostate cancer 54
Thulium Laser Supported Nephron Sparing Surgery for Renal Cell Carcinoma 53
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy 52
USE OF 3D T2-WEIGHTED MR SEQUENCES FOR THE ASSESSMENT OF NEUROVASCULAR BUNDLE CHANGES AFTER NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY (RRP): A POTENTIAL DIAGNOSTIC TOOL FOR OPTIMAL MANAGEMENT OF ERECTILE DYSFUNCTION AFTER RRP 52
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis 52
Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients 49
Cromogranin A e rischio di progressione biochimica dopo prostatectomia radicale per adenocarcinoma prostatico: follow-up fino a 10 anni. 48
A Biofeedback guided program or pelvic floor muscle electric stimulation can improve early recovery of urinary continence after radical prostatectomy: a meta-analysis and systematic review 48
High frequency of JCV DNA detection in prostate cancer tissues 47
null 47
Esperienza a lungo termine con approccio anatomico anterogrado alla prostatectomia radicale: risultati in termini di margini chirurgici positivi 46
Distribuzione dei livelli sierici di cromogranina A nei pazienti con adenocarcinoma prostatico non metastatico e metastatico. 46
How to predict outcomes from a biofeedback and pelvic floor muscle electric stimulation program in patients with urinary incontinence after radical prostatectomy 46
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data 45
RANDOMIZED TRIAL ANALYSING THE INCIDENCE AND LOCATION OF POSITIVE SURGICAL MARGINS IN RETROGRADE VERSUS ANTEROGRADE RETROPUBIC RADICAL PROSTATECTOMY 45
Erectile function recovery after laparoscopic decompression of pudendal artery and nerve: a documented case report 44
Prospective comparative trial on nerve-sparing radical prostatectomy using a robot-assisted versus laparoscopic technique: expectation versus satisfaction and impact on surgical margins 44
Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms 44
EARLY RECOVERY OF URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY USING EARLY PELVIC FLOOR ELECTRIC STIMULATION AND BIOFEEDBACK ASSOCIATED TREATMENT 43
COMBINATION THERAPY OF ETHINYLESTRADIOL AND ESTRAMUSTINE PHOSPHATE REINTRODUCES OBJECTIVE CLINICAL RESPONSE IN PATIENTS WITH ANDROGEN ABLATION-REFRACTORY PROSTATE CANCER (EARLY EXPERIENCE) 43
The association of impaired semen quality and pregnancy rates in assisted reproduction technology cycles. systematic review and meta-analysis 43
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis 42
Totale 6.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.016
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.166 0 0 0 0 0 258 272 215 192 106 78 45
2020/2021806 60 74 32 113 23 19 32 81 68 107 176 21
2021/20221.533 46 71 131 19 195 85 31 137 135 118 264 301
2022/20231.576 320 327 99 167 159 163 20 105 135 15 49 17
2023/2024805 59 130 30 57 76 103 14 65 6 104 88 73
2024/2025997 78 171 135 203 260 150 0 0 0 0 0 0
Totale 8.774